Seeking Alpha

Cellceutix Corp. (CTIX)

- OTCPK - Current
  • SA Editor Mike Taylor | Send Message 13 Feb
      • KarinCA | Send Message 9 Feb

        Cellceutix $CTIX CEO Leo Ehrlich Interviewed $CTIX
          • ellaruth | Send Message 9 Feb

            Bio-Hedge Believes Cellceutix Will Return 100 To 200 Times His Money $CTIX
              • KarinCA | Send Message 8 Feb

                $CTIX submitted an application to the NASDAQ Exchange for uplisting... ...
                Reply (3)
              • View all 3 replies
                • KarinCA | Send Message 9 Feb
                  : This is the first time they applied to uplist.
                • BiotechX | Send Message 9 Feb
                  : Sounds good to me and will give them more visibility.
                  • ellaruth | Send Message 8 Feb

                    Feb 5, 2015, Cellceutix Application To NASDAQ Made $CTIX
                      • Bleecker Street Research | Send Message 6 Feb

                        Cellceutix: Why An Uplisting Is Not Possible Right Now $CTIX
                          • ellaruth | Send Message 5 Feb

                            World Cancer Day! 8 Year Old Girl Makes Suggestion To Cure Cancer $CTIX
                              • ellaruth | Send Message 1 Feb

                                World Cancer Day, Black History Month, Margaret Hamburg And The President $CTIX
                                  • KarinCA | Send Message 29 Jan

                                    Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon $CTIX
                                      • ellaruth | Send Message 29 Jan

                                        Barron's Article By Robin Goldwyn Blumenthal On Cellceutix & Nanoantibiotics $CTIX, $NNAB, $CELG
                                          Visit Seeking Alpha's
                                          CTIX vs. ETF Alternatives
                                          Company Description
                                          An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States